To investigate whether cordycepin influences the stemness of myeloid leukemia, U937 and K562 cells were treated with cordycepin (50 μM) for 24 h and the percentage of CD34+CD38− cells were determined by flow cytometry analysis. This evidence concerns the gene CD38 and myeloid leukemia.